US FDA News 2/3

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

FDA Drug Approvals | 2024 | iPharmaCenter

FDA Drug Approvals | 2024 | iPharmaCenter

ipharmaservices

Apr 20, 2024

0

FDA approved Orchard Therapeutics' Lenmeldy for juvenile metachromatic leukodystrophy | FDA Approvals | News | iPharmaCenter

FDA approved Orchard Therapeutics' Lenmeldy for juvenile metachromatic leukodystrophy | FDA Approvals | News | iPharmaCenter

ipharmaservices

Mar 20, 2024

0

FDA Gives Green Light to First Medication for Individuals with Liver Scarring Stemming from Fatty Liver Condition | iPharmaCenter

ipharmaservices

Mar 16, 2024

0

2023 | FDA Drug Approvals | US Pharma News | iPharmaCenter

2023 | FDA Drug Approvals | US Pharma News | iPharmaCenter

ipharmaservices

Dec 21, 2023

0

FDA Greenlights First Treatment for Uncommon Non-Cancerous Growth | FDA Approvals | iPharmaCenter

FDA Greenlights First Treatment for Uncommon Non-Cancerous Growth | FDA Approvals | iPharmaCenter

ipharmaservices

Nov 30, 2023

0

Chikungunya | Drugs | Vaccines | News | Updates | iPharmaCenter

Chikungunya | Drugs | Vaccines | News | Updates | iPharmaCenter

ipharmaservices

Nov 18, 2023

0

Project Orbis News | Updates | Truqap approved in the US

ipharmaservices

Nov 18, 2023

0

FDA-Approved Chronic Weight Management Drug Zepbound, rival to Wegovy

FDA-Approved Chronic Weight Management Drug Zepbound, rival to Wegovy

ipharmaservices

Nov 12, 2023

0

UCB potential multi-billion blockbuster Bimzelx approved for plaque psoriasis | FDA | iPharmaCenter

UCB potential multi-billion blockbuster Bimzelx approved for plaque psoriasis | FDA | iPharmaCenter

ipharmaservices

Oct 18, 2023

0

Pfizer's Abrysvo approved in US to prevent RSV infection in infants |iPharmaCenter

Pfizer's Abrysvo approved in US to prevent RSV infection in infants |iPharmaCenter

ipharmaservices

Aug 22, 2023

0

Pfizer's Elrexfio approved for heavily pretreated multiple myeloma patients | iPharmaCenter

Pfizer's Elrexfio approved for heavily pretreated multiple myeloma patients | iPharmaCenter

ipharmaservices

Aug 14, 2023

0

FDA gave nod for Zurzuvae to treat postpartum depression but NO to major depressive disorder

FDA gave nod for Zurzuvae to treat postpartum depression but NO to major depressive disorder

ipharmaservices

Aug 5, 2023

0

FDA Approved RSV treatments | iPharmaCneter

FDA Approved RSV treatments | iPharmaCneter

ipharmaservices

Jul 17, 2023

0

BioMarin Pharmaceutical's $2.9 million gene therapy Roctavian was approved for haemophilia A

BioMarin Pharmaceutical's $2.9 million gene therapy Roctavian was approved for haemophilia A

ipharmaservices

Jun 29, 2023

0

FDA Approved diabetic treatments | 2023 |

FDA Approved diabetic treatments | 2023 |

ipharmaservices

Jun 28, 2023

0

FDA Approved Myasthenia gravis treatments | News | Updates | iPharmaCenter

ipharmaservices

Jun 27, 2023

0

US FDA approved drugs for Duchenne Muscular Dystrophy | Elevidys | Viltepso | iPharmaCenter

ipharmaservices

Jun 23, 2023

0

FDA News and Updates | US Pharma News | iPharmaCenter

FDA News and Updates | US Pharma News | iPharmaCenter

ipharmaservices

Jun 21, 2023

0

2022 FDA Drug Approvals | US Pharma News | iPharmaCenter

2022 FDA Drug Approvals | US Pharma News | iPharmaCenter

ipharmaservices

Feb 7, 2023

0

US FDA Withdrawals | News | Blenrep was withdrawn from the US market | iPharmaCenter

US FDA Withdrawals | News | Blenrep was withdrawn from the US market | iPharmaCenter

ipharmaservices

Nov 23, 2022

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page